It does seem strange they'd mention mid 2024, particularly when first patient dosed announcement was Jan 17 this year. Assuming at least a 3-4 month follow-up then they're predicting 26 enrolments in the space of a few months? Odd. Would have to be super quick enrolment. They did mention that historically Korea enrolment in pancreatic ca trials has been strong, but this seems a big stretch.
The Korea link is intriguing.
It does seem strange they'd mention mid 2024, particularly when...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
0.001(1.64%) |
Mkt cap ! $12.02M | |||
| Open | High | Low | Value | Volume |
| 6.1¢ | 6.3¢ | 6.0¢ | $9.66K | 160.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 302514 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.2¢ | 132017 | 1 |
View Market Depth
| Last trade - 14.58pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
6.0¢ |
Change
0.001 ( 1.64 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.0¢ | 6.0¢ | 15180 | ||
| Last updated 13.20pm 30/04/2024 ? | |||||
| ATX (ASX) Chart |